Key Financial Data Of Reporting Company

Chiome Bioscience Inc. - Filing #7712301

Concept As at
2019-03-31
2019-01-01 to
2019-03-31
As at
2018-12-31
2018-01-01 to
2018-12-31
As at
2018-03-31
2018-01-01 to
2018-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
63,782,000 JPY
212,851,000 JPY
45,354,000 JPY
Ordinary profit (loss)
-432,460,000 JPY
-1,533,952,000 JPY
-300,612,000 JPY
Profit (loss)
-430,731,000 JPY
-1,533,502,000 JPY
-301,217,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
5,855,950,000 JPY
5,454,775,000 JPY
5,454,775,000 JPY
Total number of issued shares
30,303,500 xbrli:shares
26,781,500 xbrli:shares
26,781,500 xbrli:shares
Net assets
3,048,065,000 JPY
2,676,719,000 JPY
3,917,042,000 JPY
Total assets
3,266,619,000 JPY
2,831,193,000 JPY
4,075,688,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-15.59
-57.26
-11.25
Diluted earnings per share
Equity-to-asset ratio
0.925 xbrli:pure
0.935 xbrli:pure
0.952 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.